Welcome, Dr. Kavita Lamror, and congratulations on your appointment as Partner, RWE and Digital Transformation at MCS. Your background is truly impressive. Can you tell us about your vision for Real World Evidence (RWE) and how it aligns with MCS’ mission?
You’ve been instrumental in developing key custom RWE products and merging and acquiring digital RWE product-based US companies. How do you plan to amplify the Real World Evidence Strategy at MCS?
How are you and your team working to innovate in the field of Real World Evidence solutions, and what strategies are you employing to stay current with the latest developments and changes in this area?
Collaboration and partnerships often play a crucial role in advancing the field of RWE. How do you plan to foster collaboration within MCS and with external partners, such as pharmaceutical and life sciences companies, to drive innovation and success in Real World Evidence solutions?
Digital Transformation is a buzzword in the industry. How do you envision leading Digital Transformation at MCS, especially in the context of RWE?
Your role also includes Talent Identification and Nurturing Highly Skilled Teams. Can you elaborate on this aspect?
You have a rich background in academia, pharma, and the services sector. How do you think this diverse experience will contribute to MCS’ goals?
Finally, what excites you the most about joining Maxis Clinical Sciences, and what can we expect in the near future?